Aberrant microRNA expression in endometrial carcinoma using formalin-fixed paraffin-embedded (FFPE) tissues

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lee, Taek Sang ^a   Jeon, Hye Won ^a   Kim, Yong Beom ^b   Kim, Young A ^a   Kim, Min A ^c   Kang, Soon Beom ^d  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Konkuk University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 141; MICRORNA 182; MICRORNA 200A; MICRORNA 200B; MICRORNA 205; PACLITAXEL;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL VIABILITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOMETRIUM CARCINOMA; FEMALE; FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE FIXATION; TUMOR INVASION; UPREGULATION; VERY ELDERLY;

CARCINOGENESIS; CARCINOMA, ENDOMETRIOID; DNA PRIMERS; FEMALE; FORMALDEHYDE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; PARAFFIN EMBEDDING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

EID: 84892618758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081421     Document Type: Article

References (33)

1. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
2. Rajewsky N, Socci ND (2004) Computational identification of microRNA targets. Dev Biol 267: 529-535.
3. Chen X (2004) A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development. Science 303:2022-2025.
4. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
5. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM (2006) MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587.
6. Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
7. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9: R28.
8. Kang S, Lee JM, Lee JK, Kim JW, Cho CH, et al. (2012) How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study. J Gynecol Oncol 23: 251-256.
9. Pecorelli S, Pasinetti B, Angioli R, Favalli G, Odicino F (2005) Systemic therapy for gynecological neoplasms: ovary, cervix, and endometrium. Cancer Chemother Biol Response Modif 22: 515-544.
10. Pan Q, Luo X, Toloubeydokhti T, Chegini N (2007) The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 13: 797-806.
11. Chen X, Yan Q, Li S, Zhou L, Yang H, et al. (2012) Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett 314: 41-53.
12. Hall JS, Taylor J, Valentine HR, Irlam JJ, Eustace A, et al. (2012) Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation. Br J Cancer 107: 684-694.
13. Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, et al. (2012) MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther 10:748-757.
14. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, et al. (2008) MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol 110:206-215.
15. Chung TK, Cheung TH, Huen NY, Wong KW, Lo KW, et al. (2009) Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer 124: 1358-1365.
16. Wu W, Lin Z, Zhuang Z, Liang X (2009) Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 18:50-55.
17. Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, et al. (2010) MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol 118: 251-257.
18. Cohn DE, Fabbri M, Valeri N, Alder H, Ivanov I, et al. (2010) Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol 202: 656 e1-8.
19. Wright JA, Richer JK, Goodall GJ (2010) microRNAs and EMT in mammary cells and breast cancer. J Mammary Gland Biol Neoplasia 15: 213-223.
20. Karaayvaz M, Zhang C, Liang S, Shroyer KR, Ju J (2012) Prognostic significance of miR-205 in endometrial cancer. PLoS One 7: e35158.
21. Takano M, Lu Z, Goto T, Fusi L, Higham J, et al. (2007) Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. Mol Endocrinol 21: 2334-2349.
22. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, et al. (2010) MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116: 5637-5649.
23. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, et al. (2007) Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13: 1668-1674.
24. Zhang X, Chen J, Radcliffe T, Lebrun DP, Tron VA, et al. (2008) An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J Mol Diagn 10: 513-519.
25. Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, et al. (2009) Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 89: 597-606.
26. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
27. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, et al. (2002) miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 16: 720-728.
28. Hutvagner G, Simard MJ (2008) Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 9: 22-32.
29. Lee JW, Park YA, Choi JJ, Lee YY, Kim CJ, et al. (2011) The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol 120: 56-62.
30. Hamano R, Miyata H, Yamasaki M, Kurokawa Y, Hara J, et al. (2011) Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 17: 3029-3038.
31. Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, et al. (2011) A miR-200b/200c/429- binding site polymorphism in the 3′ untranslated region of the AP-2alpha gene is associated with cisplatin resistance. PLoS One 6: e29043.
32. Feng B, Wang R, Chen LB (2012) Review of miR-200b and cancer chemosensitivity. Biomed Pharmacother 66: 397-402.
33. Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, et al. (2010) Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 127: 1785-1794.